Company / Operating Cash Flow
Baxter International Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$845.0M
FY2025
5-year range
$845.0M / $2.2B
FY2021-FY2025
Trend
-17.1%
vs FY2024
Sector context
#38 of 164
Health Care
What the data says
Baxter International's operating cash flow of $845M is higher than 77% of companies in the Health Care sector (FY2025). Operating Cash Flow has fluctuated over the past 10 years, ranging from $845M in FY2025 to $3.2B in FY2016.
Based on SEC 10-K filings.
$845M in FY2025 with a 5-year CAGR of -14.7%. Top quartile in the Health Care sector.
Declined from $1.7B to $845M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -11.3%
- 5-Year CAGR
- -14.7%
- 10-Year CAGR
- -
Sector benchmark
-19.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -14.7%, indicating a declining trend.
- In FY2025, operating cash flow decreased 17.1% year-over-year.
- Ranks #38 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2016.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $845.0M | -17.1% |
| FY2024 | $1.0B | -41.0% |
| FY2023 | $1.7B | +42.5% |
| FY2022 | $1.2B | -45.5% |
| FY2021 | $2.2B | +19.0% |
| FY2020 | $1.9B | +9.0% |
| FY2019 | $1.7B | -15.0% |
| FY2018 | $2.0B | +17.7% |
| FY2017 | $1.7B | -46.7% |
| FY2016 | $3.2B | +81.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026